- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- monomer
- Ligands
- 3 x NAG- NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.3: 9 residues within 4Å:- Chain A: S.18, Y.19, N.20, R.44, N.167, T.204
- Ligands: NAG-NAG-NAG.1, NAG-NAG-NAG.1, SO4.21
1 PLIP interactions:1 interactions with chain A- Water bridges: A:R.44
NAG-NAG.4: 3 residues within 4Å:- Chain A: K.138, N.175, E.219
No protein-ligand interaction detected (PLIP)NAG-NAG.6: 1 residues within 4Å:- Chain A: N.266
No protein-ligand interaction detected (PLIP)NAG-NAG.7: 5 residues within 4Å:- Chain A: L.15, A.161, F.440, Q.443, N.444
1 PLIP interactions:1 interactions with chain A- Water bridges: A:Q.443
NAG-NAG.8: 3 residues within 4Å:- Chain A: D.489, N.494, Q.541
No protein-ligand interaction detected (PLIP)NAG-NAG.9: 4 residues within 4Å:- Chain A: N.363, D.366, V.559, N.560
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.363
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x ASP: ASPARTIC ACID(Non-covalent)
ASP.12: 10 residues within 4Å:- Chain A: Q.144, Q.146, A.284, A.286, M.287, E.288, E.322, E.344, Y.410
- Ligands: ZN.23
10 PLIP interactions:5 interactions with chain A, 5 Ligand-Ligand interactions- Hydrogen bonds: A:Q.144, A:E.288, A:E.344, A:Y.410, D.12, D.12, D.12
- Salt bridges: A:H.321
- Water bridges: D.12, D.12
- 10 x SO4: SULFATE ION(Non-functional Binders)
SO4.13: 7 residues within 4Å:- Chain A: P.160, Y.211, T.333, L.334, W.336, W.337, L.340
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:L.334
- Water bridges: A:N.343, A:N.343
SO4.14: 7 residues within 4Å:- Chain A: N.20, V.21, T.22, N.167, I.168, T.169
- Ligands: NAG-NAG-NAG.1
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:N.20, A:T.169, A:T.169
- Water bridges: A:E.201, A:E.201, A:F.202
SO4.15: 5 residues within 4Å:- Chain A: G.285, A.286, A.299, R.314, V.318
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:R.314
SO4.16: 3 residues within 4Å:- Chain A: R.24, K.38, G.39
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.24
- Water bridges: A:G.39
SO4.17: 2 residues within 4Å:- Chain A: K.654, R.658
2 PLIP interactions:2 interactions with chain A- Salt bridges: A:K.654, A:R.658
SO4.18: 5 residues within 4Å:- Chain A: Y.349, L.353, K.365, R.418, N.422
9 PLIP interactions:9 interactions with chain A- Hydrogen bonds: A:Y.349, A:Y.349, A:N.422
- Water bridges: A:K.365, A:K.365, A:R.418, A:R.418
- Salt bridges: A:K.365, A:R.418
SO4.19: 4 residues within 4Å:- Chain A: R.24, L.191, E.193, D.194
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:Y.26, A:E.193
- Water bridges: A:R.24
- Salt bridges: A:R.24
SO4.20: 4 residues within 4Å:- Chain A: F.405, D.406, S.407, Y.410
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:F.405
- Water bridges: A:S.407, A:S.411
SO4.21: 7 residues within 4Å:- Chain A: N.167, K.185, F.202, T.204
- Ligands: NAG-NAG-NAG.1, NAG-NAG-NAG.1, NAG-NAG.3
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:T.204, A:T.204
- Water bridges: A:E.203
- Salt bridges: A:K.185
SO4.22: 2 residues within 4Å:- Chain A: Q.1, R.7
5 PLIP interactions:5 interactions with chain A- Water bridges: A:S.2, A:R.7, A:R.7, A:R.7
- Salt bridges: A:R.7
- 1 x ZN: ZINC ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Joshi, S. et al., The Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach. Sci Rep (2017)
- Release Date
- 2018-01-17
- Peptides
- Aminopeptidase N: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- monomer
- Ligands
- 3 x NAG- NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x ASP: ASPARTIC ACID(Non-covalent)
- 10 x SO4: SULFATE ION(Non-functional Binders)
- 1 x ZN: ZINC ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Joshi, S. et al., The Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach. Sci Rep (2017)
- Release Date
- 2018-01-17
- Peptides
- Aminopeptidase N: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A